Veli Bakalov, Oncologist at MD Anderson Cancer center at Cooper University Health Care and Author of HemeOncBuddy app, shared a post on X:
“Announcement.
My first investigator-initiated clinical trial, INSPIRE-CRT, is now open for enrollment at MD Anderson Cancer Center at Cooper University Health Care.
We are studying if incentive spirometry can reduce pneumonitis rates, severity, and hospitalizations in lung cancer patients undergoing chemoradiation and maintenance treatment (ICI or TKI).
Your support matters.
If interested in opening this trial at your site, please DM for details.
Together, let’s improve outcomes and quality of life for lung cancer patients.”
For more updates, follow OncoDaily.
